# Use of Testosterone to Prevent Post-Surgical Muscle Loss - Pilot Study

> **NCT04456530** · PHASE2,PHASE3 · UNKNOWN · sponsor: **The Stone Research Foundation for Sports Medicine and Arthritis** · enrollment: 15 (estimated)

## Conditions studied

- Muscle Atrophy
- Surgery
- Knee Injuries and Disorders
- Complication of Surgical Procedure
- Trauma

## Interventions

- **DRUG:** Aveed 750 MG in 3 ML IM Injection
- **OTHER:** Normal Saline 3 ML IM Injection

## Key facts

- **NCT ID:** NCT04456530
- **Lead sponsor:** The Stone Research Foundation for Sports Medicine and Arthritis
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-08
- **Primary completion:** 2021-12-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2021-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04456530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04456530, "Use of Testosterone to Prevent Post-Surgical Muscle Loss - Pilot Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04456530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*